---
company: Quanex Building Products CORP
ticker: NX
form: 8-K
filed: 2026-09-03
accession: 0001171843-26-005882
source: https://www.sec.gov/Archives/edgar/data/1423221/000117184326005882/
---

# Quanex Building Products (NX) earnings release, September 3, 2026

Quanex Building Products CORP (NX) · Form 8-K, Item 2.02 · Filed 2026-09-03 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1423221/000117184326005882/)

Quanex Building Products Announces Third Quarter 2026 Results

Net Sales Growth

Volumes Continue to Track Normal Seasonality Patterns

Margin Expansion Realized in Hardware Solutions Segment and on Consolidated Basis

$42.25 Million of Debt Repaid in 3Q26

Continued Progress and Execution on Working Capital Management

HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) --

Quanex Building Products Corporation

(NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended July 31, 2026.

The Company reported the following selected financial results:

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, stated, “Volumes continued to track normal seasonality patterns during the third quarter of 2026, and we made meaningful progress addressing the price versus cost imbalance that impacted our margins in the second quarter of 2026. Inflationary pressures related to macroeconomic concerns and the ongoing conflict in the Middle East are still having an impact, but the initial rate and magnitude of these pressures have somewhat subsided.

“We stayed focused on managing our working capital during the third quarter of 2026, which when coupled with the seasonal uptick in volumes, enabled us to repay $42.25 million of debt and buy back some of our shares. We will continue to prioritize repaying debt and opportunistically repurchasing our shares as we generate cash in the fourth quarter of 2026. In addition, we will continue to identify operational efficiencies and commercial synergies that we believe will benefit us when consumer confidence and demand improve.”

Third Quarter 2026 Results Summary

Quanex reported net sales of $501.8 million during the three months ended July 31, 2026, which represents an increase of 1.3% compared to $495.3 million for the same period in 2025, mainly due to favorable impacts from pricing, partially offset by the impact of IEEPA tariff reimbursements to customers. The Hardware Solutions segments reported a 2.7% decline in net sales for the third quarter of 2026, driven by lower volumes and the impact of IEEPA tariff reimbursements to customers, which were somewhat offset by favorable impacts from pricing. The Extruded Solutions segments reported net sales growth of 2.8% for the third quarter of 2026, as lower volumes were more than offset by favorable impacts from pricing. Quanex reported an increase of 8.5% in net sales for the third quarter of 2026 in its Custom Solutions segment, largely due to increased volume and improved pricing. (See Sales Analysis table for additional information)

On a consolidated basis, the increase in reported earnings for the third quarter of 2026 compared to the third quarter of 2025 was mainly due to improved pricing, lower depreciation and amortization expense and lower interest expense. Results for the third quarter of 2025 were also impacted by a $302.3 million non-cash goodwill impairment.

Balance Sheet & Liquidity Update

As of July 31, 2026, the Company had total debt of $672.2 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA was 2.8x. As of July 31, 2026, Quanex reported LTM Net Income of $45.4 million and LTM Adjusted EBITDA of $215.2 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The Company’s liquidity increased by 10.5% to $363.1 million as of July 31, 2026, consisting of $62.1 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Share Repurchases

Quanex’s Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 99,786 shares of common stock for approximately $1.7 million at an average price of $17.10 per share during the three months ended July 31, 2026. As of July 31, 2026, approximately $28.7 million remained under the existing share repurchase authorization.

Conference Call and Webcast Information

The Company has scheduled a conference call for Friday, September 4, 2026, at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register-conf.media-server.com/register/BIac7900426be941999342c141e5049229

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently partners with leading OEMs to provide innovative solutions in window, door, solar, refrigeration, custom mixing, building access and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Non-GAAP Terminology Definitions and Disclaimers... (truncated)and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflect operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities. These measures allow management and investors to evaluate operational performance and trends without the impact of certain non-cash charges, acquisition-related costs, and other items that may vary significantly from period to period and may not be reflective of Quanex’s core operating results. The presented non-GAAP measures may not be the same as those used by other companies. The Company does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” “anticipate,” “intend,” “plan,” “project,” “seek,” “would,” “may,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: Quanex’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to the Company’s industry, expectations regarding the recovery of price versus cost imbalances, anticipated debt repayment and share repurchase activity, expected operational efficiencies and synergies and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from those expressed or implied in these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. For a complete discussion of factors that may affect the Company’s future performance, please refer to Quanex’s Annual Report on Form 10-K for the fiscal year ended October 31, 2025, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether written or oral, to reflect new information, developments or events.

## Financial statements

### Income Statement (Three Months Ended July 31, — The Company reported the following selected financial results: ($ in millions, except per share data))

| | Three Months Ended July 31, – 2026 | Three Months Ended July 31, – 2025 | Nine Months Ended July 31, – 2026 | Nine Months Ended July 31, – 2025 |
|---|---:|---:|---:|---:|
| Net Sales | 501.8 | 495.3 | 1,373.3 | 1,347.8 |
| Gross Margin | 141.5 | 138 | 357.8 | 361.7 |
| Gross Margin % | 28.2% | 27.9% | 26.1% | 26.8% |
| Operating Income (Loss) | 46.5 | -270.8 | 68.1 | -236.9 |
| Net Income (Loss) | 26.5 | -276 | 25.8 | -270.4 |
| Diluted EPS | 0.58 | -6.04 | 0.57 | -5.83 |
| Adjusted Net Income | 36 | 31.6 | 47 | 68.4 |
| Adjusted Diluted EPS | 0.79 | 0.69 | 1.03 | 1.47 |
| Adjusted EBITDA | 72.7 | 70.3 | 144.3 | 172 |
| Adjusted EBITDA Margin % | 14.5% | 14.2% | 10.5% | 12.8% |
| Cash Provided By Operating Activities | 58.6 | 60.7 | 57.3 | 76.6 |
| Free Cash Flow | 47.8 | 46.2 | 24.2 | 35.6 |

### Income Statement (In thousands, except per share data)

| | Three Months Ended July 31, – 2026 | Three Months Ended July 31, – 2025 | Nine Months Ended July 31, – 2026 | Nine Months Ended July 31, – 2025 |
|---|---:|---:|---:|---:|
| Net sales | 501,845 | 495,273 | 1,373,301 | 1,347,795 |
| Cost of sales | 360,380 | 357,305 | 1,015,517 | 986,129 |
| Selling, general and administrative | 70,837 | 71,270 | 216,695 | 208,253 |
| Restructuring charges |  | 1,367 |  | 10,207 |
| Depreciation and amortization | 24,138 | 33,882 | 73,037 | 77,814 |
| Asset impairment charges |  | 302,284 |  | 302,284 |
| Operating income (loss) | 46,490 | -270,835 | 68,052 | -236,892 |
| Interest expense | -11,978 | -14,218 | -36,387 | -42,344 |
| Other, net | -93 | 855 | 5,972 | 1,925 |
| Income (loss) before income taxes | 34,419 | -284,198 | 37,637 | -277,311 |
| Income tax (expense) benefit | -7,915 | 8,191 | -11,854 | 6,934 |
| Net income (loss) | 26,504 | -276,007 | 25,783 | -270,377 |
| Earnings (loss) per common share, basic | 0.58 | -6.04 | 0.57 | -5.83 |
| Earnings (loss) per common share, diluted | 0.58 | -6.04 | 0.57 | -5.83 |
| Weighted average common shares outstanding: | Basic | 45,461 | 45,691 | 45,466 | 46,395 |
| Weighted average common shares outstanding: | Diluted | 45,648 | 45,691 | 45,607 | 46,395 |
| Weighted average common shares outstanding: | Cash dividends per share | 0.08 | 0.08 | 0.24 | 0.24 |

### Income Statement (In thousands, except per share data)

| | Three Months Ended July 31, 2026 – Reconciliation | Three Months Ended April 30, 2026 – Reconciliation | Three Months Ended January 31, 2026 – Reconciliation | Three Months Ended October 31, 2025 – Reconciliation | Total – Reconciliation |
|---|---:|---:|---:|---:|---:|
| Net income (loss) as reported | 26,504 | 3,350 | -4,071 | 19,571 | 45,354 |
| Income tax expense (benefit) | 7,915 | 3,766 | 173 | 15,147 | 27,001 |
| Other, net | 93 | -448 | -5,617 | -5,246 | -11,218 |
| Interest expense | 11,978 | 12,042 | 12,367 | 13,468 | 49,855 |
| Depreciation and amortization | 24,138 | 24,650 | 24,249 | 25,630 | 98,667 |
| EBITDA | 70,628 | 43,360 | 27,101 | 68,570 | 209,659 |
| Cost of sales (1) | 1,223 | 121 | 407 | 308 | 2,059 |
| Selling, general and administrative (1),(2) | 894 | 688 | -126 | 2,040 | 3,496 |
| Adjusted EBITDA | 72,745 | 44,169 | 27,382 | 70,918 | 215,214 |
| (1) Severance and other expenses related to manufacturing footprint and performance optimization. | (1) Severance and other expenses related to manufacturing footprint and performance optimization. | (1) Severance and other expenses related to manufacturing footprint and performance optimization. | (1) Severance and other expenses related to manufacturing footprint and performance optimization. | (1) Severance and other expenses related to manufacturing footprint and performance optimization. | (1) Severance and other expenses related to manufacturing footprint and performance optimization. |
| (2) Transaction, advisory fees, severance and reorganization costs. | (2) Transaction, advisory fees, severance and reorganization costs. | (2) Transaction, advisory fees, severance and reorganization costs. | (2) Transaction, advisory fees, severance and reorganization costs. | (2) Transaction, advisory fees, severance and reorganization costs. | (2) Transaction, advisory fees, severance and reorganization costs. |

### Income Statement (In thousands, except per share data)

| | Three Months Ended July 31, 2026 – Net Income | Reconciliation | Income Statement | Three Months Ended July 31, 2026 – Diluted EPS |  | Reconciling Items |  | Three Months Ended July 31, 2025 – Net Income | Reconciliation | Income Statement | Three Months Ended July 31, 2025 – Diluted EPS |  | Reconciling Items |  | Nine Months Ended July 31, 2026 – Net Income | Reconciliation | Income Statement | Nine Months Ended July 31, 2026 – Diluted EPS |  | Reconciling Items |  | Nine Months Ended July 31, 2025 – Net Income | Reconciliation | Income Statement | Nine Months Ended July 31, 2025 – Diluted EPS |  | Reconciling Items |  |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Net income (loss) as reported | 26,504 |  |  | 0.58 |  |  |  | -276,007 |  |  | -6.04 |  |  |  | 25,783 |  |  | 0.57 |  |  |  | -270,377 |  |  | -5.83 |  |  |  |
| Net income(loss) reconciling items from below | 9,507 |  |  | 0.21 |  |  |  | 307,578 |  |  | 6.73 |  |  |  | 21,221 |  |  | 0.46 |  |  |  | 338,756 |  |  | 7.3 |  |  |  |
| Adjusted net income and adjusted EPS | 36,011 |  |  | 0.79 |  |  |  | 31,571 |  |  | 0.69 |  |  |  | 47,004 |  |  | 1.03 |  |  |  | 68,379 |  |  | 1.47 |  |  |  |
| Reconciliation of Adjusted EBITDA |  |  |  | Three Months Ended July 31, 2026 |  |  |  |  |  |  | Three Months Ended July 31, 2025 |  |  |  |  |  |  | Nine Months Ended July 31, 2026 |  |  |  |  |  |  | Nine Months Ended July 31, 2025 |  |  |  |
| Net income (loss) as reported |  | 26,504 |  |  |  |  |  |  | -276,007 |  |  |  |  |  |  | 25,783 |  |  |  |  |  |  | -270,377 |  |  |  |  |  |
| Income tax expense |  | 7,915 |  |  |  |  |  |  | -8,191 |  |  |  |  |  |  | 11,854 |  |  |  |  |  |  | -6,934 |  |  |  |  |  |
| Other, net |  | 93 |  |  |  |  |  |  | -855 |  |  |  |  |  |  | -5,972 |  |  |  |  |  |  | -1,925 |  |  |  |  |  |

### Income Statement (in thousands)

| | This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. – Hardware Solutions | This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. – Extruded Solutions | This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. – Custom Solutions | This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. – Unallocated Corp & Other | This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. – Total |
|---|---:|---:|---:|---:|---:|
| Three months ended July 31, 2026 | Net sales | 220,923 | 179,291 | 111,007 | -9,376 | 501,845 |
| Three months ended July 31, 2026 | Cost of sales | 162,056 | 121,389 | 85,861 | -8,926 | 360,380 |
| Three months ended July 31, 2026 | Gross Margin | 58,867 | 57,902 | 25,146 | -450 | 141,465 |
| Three months ended July 31, 2026 | Gross Margin % | 26.6% | 32.3% | 22.7% |  | 28.2% |
| Three months ended July 31, 2026 | Selling, general and administrative (1) | 33,162 | 22,279 | 13,143 | 2,253 | 70,837 |
| Three months ended July 31, 2026 | Depreciation and amortization | 11,386 | 7,213 | 5,330 | 209 | 24,138 |
| Three months ended July 31, 2026 | Operating (loss) income | 14,319 | 28,410 | 6,673 | -2,912 | 46,490 |
| Three months ended July 31, 2026 | Depreciation and amortization | 11,386 | 7,213 | 5,330 | 209 | 24,138 |
| Three months ended July 31, 2026 | EBITDA | 25,705 | 35,623 | 12,003 | -2,703 | 70,628 |
| Three months ended July 31, 2026 | Expense related to plant relocation and closure (Cost of sales) | 1,223 |  |  |  | 1,223 |
| Three months ended July 31, 2026 | Reorganization and severance costs | 127 | 1 |  | 766 | 894 |
| Three months ended July 31, 2026 | Adjusted EBITDA | 27,055 | 35,624 | 12,003 | -1,937 | 72,745 |
| Three months ended July 31, 2026 | Adjusted EBITDA Margin % | 12.2% | 19.9% | 10.8% |  | 14.5% |
| Three months ended July 31, 2025 | Net sales | 227,116 | 174,427 | 102,264 | -8,534 | 495,273 |
| Three months ended July 31, 2025 | Cost of sales | 170,282 | 116,597 | 77,755 | -7,329 | 357,305 |
| Three months ended July 31, 2025 | Gross Margin | 56,834 | 57,830 | 24,509 | -1,205 | 137,968 |
| Three months ended July 31, 2025 | Gross Margin % | 25.0% | 33.2% | 24.0% |  | 27.9% |
| Three months ended July 31, 2025 | Selling, general and administrative (1) | 32,954 | 20,740 | 11,708 | 5,868 | 71,270 |
| Three months ended July 31, 2025 | Restructuring charges | 1,140 | 34 | 26 | 167 | 1,367 |
| Three months ended July 31, 2025 | Depreciation and amortization | 16,987 | 6,989 | 4,716 | 5,190 | 33,882 |
| Three months ended July 31, 2025 | Asset impairment charges | 163,198 | 54,934 | 84,152 |  | 302,284 |
| Three months ended July 31, 2025 | Operating income (loss) | -157,445 | -24,867 | -76,093 | -12,430 | -270,835 |
| Three months ended July 31, 2025 | Depreciation and amortization | 16,987 | 6,989 | 4,716 | 5,190 | 33,882 |
| Three months ended July 31, 2025 | Asset impairment charges | 163,198 | 54,934 | 84,152 |  | 302,284 |
| Three months ended July 31, 2025 | EBITDA | 22,740 | 37,056 | 12,775 | -7,240 | 65,331 |
| Three months ended July 31, 2025 | Expense related to plant relocation and closure (Cost of sales) | 148 |  |  |  | 148 |
| Three months ended July 31, 2025 | Transaction, advisory fees, reorganization costs, and product recall expenses | 715 |  | 50 | 2,684 | 3,449 |
| Three months ended July 31, 2025 | Restructuring charges | 1,140 | 34 | 26 | 167 | 1,367 |
| Three months ended July 31, 2025 | Adjusted EBITDA | 24,743 | 37,090 | 12,851 | -4,389 | 70,295 |
| Three months ended July 31, 2025 | Adjusted EBITDA Margin % | 10.9% | 21.3% | 12.6% |  | 14.2% |
| Nine months ended July 31, 2026 | Net sales | 613,054 | 484,040 | 304,062 | -27,855 | 1,373,301 |
| Nine months ended July 31, 2026 | Cost of sales | 475,172 | 331,979 | 236,302 | -27,936 | 1,015,517 |
| Nine months ended July 31, 2026 | Gross Margin | 137,882 | 152,061 | 67,760 | 81 | 357,784 |
| Nine months ended July 31, 2026 | Gross Margin % | 22.5% | 31.4% | 22.3% |  | 26.1% |
| Nine months ended July 31, 2026 | Selling, general and administrative (1) | 103,105 | 65,084 | 40,182 | 8,324 | 216,695 |
| Nine months ended July 31, 2026 | Depreciation and amortization | 34,626 | 21,893 | 15,956 | 562 | 73,037 |
| Nine months ended July 31, 2026 | Operating (loss) income | 151 | 65,084 | 11,622 | -8,805 | 68,052 |
| Nine months ended July 31, 2026 | Depreciation and amortization | 34,626 | 21,893 | 15,956 | 562 | 73,037 |
| Nine months ended July 31, 2026 | EBITDA | 34,777 | 86,977 | 27,578 | -8,243 | 141,089 |
| Nine months ended July 31, 2026 | Expense related to plant relocation and closure (Cost of sales) | 1,751 |  |  |  | 1,751 |
| Nine months ended July 31, 2026 | Credit related to plant relocation (SG&A) | -8 |  |  |  | -8 |
| Nine months ended July 31, 2026 | Reorganization and severance costs | 273 | 1 | 1 | 1,189 | 1,464 |
| Nine months ended July 31, 2026 | Adjusted EBITDA | 36,793 | 86,978 | 27,579 | -7,054 | 144,296 |
| Nine months ended July 31, 2026 | Adjusted EBITDA Margin % | 6.0% | 18.0% | 9.1% |  | 10.5% |
| Nine months ended July 31, 2025 | Net sales | 614,791 | 478,024 | 284,809 | -29,829 | 1,347,795 |
| Nine months ended July 31, 2025 | Cost of sales | 466,600 | 325,914 | 219,755 | -26,140 | 986,129 |

### Income Statement (in thousands)

| | Three Months Ended July 31, – 2026 | Three Months Ended July 31, – 2025 | Nine Months Ended July 31, – 2026 | Nine Months Ended July 31, – 2025 |
|---|---:|---:|---:|---:|
| Window and door hardware | 133,038 | 148,303 | 387,047 | 405,497 |
| Screens | 85,830 | 76,809 | 219,980 | 203,269 |
| Other | 2,055 | 2,004 | 6,027 | 6,025 |
|  | 220,923 | 227,116 | 613,054 | 614,791 |
| Extruded Solutions:(2) | Window profiles | 75,684 | 76,775 | 206,581 | 206,629 |
| Extruded Solutions:(2) | Seals and gaskets | 20,241 | 20,415 | 57,405 | 57,857 |
| Extruded Solutions:(2) | Spacers | 59,996 | 55,201 | 160,124 | 148,733 |
| Extruded Solutions:(2) | Solar | 5,375 | 5,250 | 15,292 | 17,835 |
| Extruded Solutions:(2) | Flashing Tape | 2,821 | 3,038 | 7,567 | 6,751 |
| Extruded Solutions:(2) | Window and door hardware | 10,079 | 10,676 | 26,061 | 31,311 |
| Extruded Solutions:(2) | Other | 5,095 | 3,072 | 11,010 | 8,908 |
| Extruded Solutions:(2) |  | 179,291 | 174,427 | 484,040 | 478,024 |
| Custom Solutions:(3) | Wood solutions | 59,282 | 53,409 | 162,841 | 148,456 |
| Custom Solutions:(3) | Access solutions | 29,483 | 27,370 | 78,984 | 74,158 |
| Custom Solutions:(3) | Mixing solutions | 22,242 | 21,485 | 62,237 | 62,195 |
| Custom Solutions:(3) |  | 111,007 | 102,264 | 304,062 | 284,809 |
| Unallocated Corporate & Other: | Eliminations | -9,376 | -8,534 | -27,855 | -29,829 |
| Unallocated Corporate & Other: | ) | -9,376 | -8,534 | -27,855 | -29,829 |
| Unallocated Corporate & Other: | Net Sales | 501,845 | 495,273 | 1,373,301 | 1,347,795 |
| Unallocated Corporate & Other: | (1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively. | (1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively. | (1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively. | (1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively. | (1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively. |

### Balance Sheet (in thousands)

| | July 31, 2026 | October 31, 2025 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 62,094 | 76,018 |
| Current assets: | Restricted Cash | 2,123 | 2,100 |
| Current assets: | Accounts receivable, net | 214,768 | 205,384 |
| Current assets: | Inventories | 276,396 | 254,122 |
| Current assets: | Income taxes receivable | 5,603 |  |
| Current assets: | Prepaid assets | 37,452 | 32,387 |
| Current assets: | Other current assets | 3,847 | 3,764 |
| Current assets: | Total current assets | 602,283 | 573,775 |
| Current assets: | Property, plant and equipment, net | 394,021 | 411,591 |
| Current assets: | Operating lease right-of-use assets | 171,552 | 154,866 |
| Current assets: | Deferred tax assets | 300 | 2,706 |
| Current assets: | Goodwill | 273,765 | 271,346 |
| Current assets: | Intangible assets, net | 522,218 | 549,137 |
| Current assets: | Other assets | 4,552 | 4,812 |
| Current assets: | Total assets | 1,968,691 | 1,968,233 |
| Current liabilities: | Accounts payable | 127,030 | 131,307 |
| Current liabilities: | Accrued liabilities | 88,209 | 95,155 |
| Current liabilities: | Income taxes payable | 9,300 | 12,076 |
| Current liabilities: | Current maturities of long-term debt | 26,551 | 27,561 |
| Current liabilities: | Current operating lease liabilities | 18,822 | 15,446 |
| Current liabilities: | Total current liabilities | 269,912 | 281,545 |
| Current liabilities: | Long-term debt | 636,814 | 665,268 |
| Current liabilities: | Noncurrent operating lease liabilities | 160,290 | 145,459 |
| Deferred pension benefits | Deferred income taxes | 137,766 | 135,993 |
| Deferred pension benefits | Liabilities for uncertain tax positions | 1,857 |  |
| Deferred pension benefits | Other liabilities | 16,608 | 13,789 |
| Deferred pension benefits | Total liabilities | 1,223,247 | 1,242,054 |
| Stockholders’ equity: | Common stock | 512 | 512 |
| Stockholders’ equity: | Additional paid-in-capital | 697,598 | 700,029 |
| Stockholders’ equity: | Retained earnings | 179,472 | 164,710 |
| Stockholders’ equity: | Accumulated other comprehensive loss | -32,142 | -35,439 |
| Stockholders’ equity: | Treasury stock at cost | -99,996 | -103,633 |
| Stockholders’ equity: | Total stockholders’ equity | 745,444 | 726,179 |
| Stockholders’ equity: | Total liabilities and stockholders' equity | 1,968,691 | 1,968,233 |

### Cash Flow (in thousands)

| | Nine Months Ended July 31, – 2026 | Nine Months Ended July 31, – 2025 |
|---|---:|---:|
| Operating activities: | Net (loss) income | 25,783 | -270,377 |
| Adjustments to reconcile net loss to cash used for operating activities: | Depreciation and amortization | 73,037 | 77,814 |
| Adjustments to reconcile net loss to cash used for operating activities: | Stock-based compensation | 3,617 | 2,762 |
| Adjustments to reconcile net loss to cash used for operating activities: | Deferred income tax | 664 | -26,440 |
| Adjustments to reconcile net loss to cash used for operating activities: | Goodwill impairment charge |  | 302,284 |
| Adjustments to reconcile net loss to cash used for operating activities: | Other, net | 4,640 | 9,203 |
| Changes in assets and liabilities: | Increase in accounts receivable | -8,685 | -1,727 |
| Changes in assets and liabilities: | (Increase) decrease in inventory | -21,129 | 5,261 |
| Changes in assets and liabilities: | Increase in other current assets | -4,430 | -7,228 |
| Changes in assets and liabilities: | (Decrease) increase in accounts payable | -2,365 | 144 |
| Changes in assets and liabilities: | Decrease in accrued liabilities | -7,601 | -9,725 |
| Changes in assets and liabilities: | Change in income taxes | -6,629 | -21 |
| Changes in assets and liabilities: | Other, net | 366 | -5,307 |
| Changes in assets and liabilities: | Cash provided by operating activities | 57,268 | 76,643 |
| Investing activities: | Capital expenditures | -33,066 | -40,996 |
| Investing activities: | Proceeds from disposition of capital assets | 62 | 361 |
| Investing activities: | Cash used for investing activities | -33,004 | -40,635 |
| Financing activities: | Borrowings under credit facilities | 141,500 | 170,000 |
| Financing activities: | Repayments of credit facility borrowings | -164,250 | -213,750 |
| Financing activities: | Repayments of other long-term debt | -3,316 | -1,962 |
| Financing activities: | Common stock dividends paid | -10,916 | -11,233 |
| Financing activities: | Purchase of treasury stock | -1,707 | -29,248 |
| Financing activities: | Other, net | -704 | -1,186 |

### Cash Flow (in thousands)

| | The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. – Three Months Ended July 31, – 2026 | As of July 31, – 2026 | The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. – Three Months Ended July 31, – 2025 | As of July 31, – 2025 | The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. – Nine Months Ended July 31, – 2026 | The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. – Nine Months Ended July 31, – 2025 |  |
|---|---:|---:|---:|---:|---:|---:|---:|
| Cash provided by operating activities | 58,554 |  | 60,656 |  | 57,268 | 76,643 |  |
| Capital expenditures | -10,744 |  | -14,452 |  | -33,066 | -40,996 |  |
| Free Cash Flow | 47,810 |  | 46,204 |  | 24,202 | 35,647 |  |
| The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. |  |  | The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. |  |  | The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. |  |
| Term loan facility |  | 450,000 |  | 475,000 |  |  |  |
| Revolving credit facility |  | 168,500 |  | 197,500 |  |  |  |
| Finance lease obligations (1) |  | 53,697 |  | 61,194 |  |  |  |
| Total debt (2) |  | 672,197 |  | 733,694 |  |  |  |
| Less: Cash and cash equivalents |  | 62,094 |  | 66,272 |  |  |  |
| Net Debt |  | 610,103 |  | 667,422 |  |  |  |
| (1) Includes $47.9 million and $58.9 million in real estate lease liabilities considered finance leases under U.S. GAAP as of July 31, 2026 and 2025, respectively. |  |  |  | (1) Includes $47.9 million and $58.9 million in real estate lease liabilities considered finance leases under U.S. GAAP as of July 31, 2026 and 2025, respectively. |  |  | (1) Includes $47.9 million and $58.9 million in real estate lease liabilities considered finance leases under U.S. GAAP as of July 31, 2026 and 2025, respectively. |
| (2) Excludes outstanding letters of credit. |  |  |  | (2) Excludes outstanding letters of credit. |  |  | (2) Excludes outstanding letters of credit. |
